Ausgabe 4/2018
Inhalt (7 Artikel)
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer
Sasha M. Pejerrey, Derek Dustin, Jin-Ah Kim, Guowei Gu, Yassine Rechoum, Suzanne A. W. Fuqua
Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk
H. Zhao, J. Wang, D. Fang, O. Lee, R. T. Chatterton, V. Stearns, S. A. Khan, S. E. Bulun
The Impact of Hormonal Contraceptives on Breast Cancer Pathology
Jesse A. Dorchak, Sifat Maria, Joseph L. Guarinoni, Anette Duensing, Stella Somiari, Jane Cavanaugh, Brenda Deyarmin, Hai Hu, Joji Iida, Craig D. Shriver, Paula A. Witt-Enderby
The Influence of Menopausal Hormone Therapy and Potential Lifestyle Interactions in Female Cancer Development—a Population-Based Prospective Study
Marianne Holm, Anja Olsen, Cecilie Kyrø, Kim Overvad, Niels Kroman, Anne Tjønneland
The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus
Matthew Dean, Julia Austin, Ren Jinhong, Michael E. Johnson, Daniel D. Lantvit, Joanna E. Burdette
Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome
Zongping Chen, Jichun Deng, Yong Yan, Min Li, Chanjuan Chen, Chao Chen, Sicong Zhao, Tao Song, Tong Liu, Xin Wen, Yuhong Yao
Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer
Laurel Grant, Shantanu Banerji, Leigh Murphy, David E. Dawe, Craig Harlos, Yvonne Myal, Zoann Nugent, Anne Blanchard, Carla R. Penner, Gefei Qing, Marshall W. Pitz